BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 17916030)

  • 1. Evaluation of cisplatin administered with piroxicam in dogs with transitional cell carcinoma of the urinary bladder.
    Greene SN; Lucroy MD; Greenberg CB; Bonney PL; Knapp DW
    J Am Vet Med Assoc; 2007 Oct; 231(7):1056-60. PubMed ID: 17916030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993).
    Chun R; Knapp DW; Widmer WR; Glickman NW; DeNicola DB; Bonney PL
    J Am Vet Med Assoc; 1996 Nov; 209(9):1588-91. PubMed ID: 8899023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma.
    Upton ML; Tangner CH; Payton ME
    J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma.
    Henry CJ; McCaw DL; Turnquist SE; Tyler JW; Bravo L; Sheafor S; Straw RC; Dernell WS; Madewell BR; Jorgensen L; Scott MA; Higginbotham ML; Chun R
    Clin Cancer Res; 2003 Feb; 9(2):906-11. PubMed ID: 12576466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
    Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL
    J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma.
    Schrempp DR; Childress MO; Stewart JC; Leach TN; Tan KM; Abbo AH; de Gortari AE; Bonney PL; Knapp DW
    J Am Vet Med Assoc; 2013 Jun; 242(11):1534-8. PubMed ID: 23683018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.
    Robat C; Burton J; Thamm D; Vail D
    J Small Anim Pract; 2013 Feb; 54(2):67-74. PubMed ID: 23286739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer.
    Knapp DW; Glickman NW; Widmer WR; DeNicola DB; Adams LG; Kuczek T; Bonney PL; DeGortari AE; Han C; Glickman LT
    Cancer Chemother Pharmacol; 2000; 46(3):221-6. PubMed ID: 11021739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder.
    McMillan SK; Boria P; Moore GE; Widmer WR; Bonney PL; Knapp DW
    J Am Vet Med Assoc; 2011 Oct; 239(8):1084-9. PubMed ID: 21985349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study.
    Poirier VJ; Forrest LJ; Adams WM; Vail DM
    J Am Anim Hosp Assoc; 2004; 40(2):131-6. PubMed ID: 15007049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
    Henry CJ; Flesner BK; Bechtel SA; Bryan JN; Tate DJ; Selting KA; Lattimer JC; Bryan ME; Grubb L; Hausheer F
    J Vet Intern Med; 2018 Jan; 32(1):370-376. PubMed ID: 29080252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder.
    Arnold EJ; Childress MO; Fourez LM; Tan KM; Stewart JC; Bonney PL; Knapp DW
    J Vet Intern Med; 2011; 25(6):1385-90. PubMed ID: 22092632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.
    Marconato L; Zini E; Lindner D; Suslak-Brown L; Nelson V; Jeglum AK
    J Am Vet Med Assoc; 2011 Apr; 238(8):1004-10. PubMed ID: 21492043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder.
    Marvel SJ; Séguin B; Dailey DD; Thamm DH
    Vet Comp Oncol; 2017 Dec; 15(4):1417-1427. PubMed ID: 28217972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder.
    Knapp DW; Richardson RC; Chan TC; Bottoms GD; Widmer WR; DeNicola DB; Teclaw R; Bonney PL; Kuczek T
    J Vet Intern Med; 1994; 8(4):273-8. PubMed ID: 7983623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004).
    Wilson HM; Chun R; Larson VS; Kurzman ID; Vail DM
    J Am Vet Med Assoc; 2007 Jul; 231(1):101-6. PubMed ID: 17605672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
    Mohammed SI; Craig BA; Mutsaers AJ; Glickman NW; Snyder PW; deGortari AE; Schlittler DL; Coffman KT; Bonney PL; Knapp DW
    Mol Cancer Ther; 2003 Feb; 2(2):183-8. PubMed ID: 12589035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin for treatment of transitional cell and squamous cell carcinomas in dogs.
    Shapiro W; Kitchell BE; Fossum TW; Couto CG; Theilen G
    J Am Vet Med Assoc; 1988 Dec; 193(12):1530-3. PubMed ID: 3215812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
    Vinall RL; Kent MS; deVere White RW
    Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.
    Boria PA; Murry DJ; Bennett PF; Glickman NW; Snyder PW; Merkel BL; Schlittler DL; Mutsaers AJ; Thomas RM; Knapp DW
    J Am Vet Med Assoc; 2004 Feb; 224(3):388-94. PubMed ID: 14765798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.